Week to week variability of pulmonary capillary blood volume and alveolar membrane diffusing capacity in patients with heart failure.

Respiratory Physiology & Neurobiology
Alessandra MaginiPiergiuseppe Agostoni

Abstract

Alveolar-capillary membrane diffusing capacity for carbon monoxide (DMCO) and pulmonary capillary volume (Vcap) can be estimated by the multi-step Roughton and Foster (RF, original method from 1957) or the single-step NO-CO double diffusion technique (developed in the 1980s). The latter method implies inherent assumptions. We sought to determine which combination of the alveolar membrane diffusing capacity for nitric oxide (DMNO) to DMCO ratio, an specific conductance of the blood for NO (θNO) and CO (θCO) gave the lowest week-to-week variability in patients with heart failure. 44 heart failure patients underwent DMCO and Vcap measurements on three occasions over a ten-week period using both RF and double dilution NO-CO techniques. When using the double diffusing method and applying θNO = infinity, the smallest week-to-week coefficient of variation for DMCO was 10 %. Conversely, the RF method derived DMCO had a much greater week-to-week variability (2x higher coefficient of variation) than the DMCO derived via the NO-CO double dilution technique. The DMCO derived from the double diffusion technique most closely matched the DMCO from the RF method when θNO = infinity and DMCO = DLNO/2.42. The Vcap measured week-to-week was unrel...Continue Reading

References

Feb 1, 1984·The American Review of Respiratory Disease·J E HansenK Wasserman
Jun 29, 1996·BMJ : British Medical Journal·J M Bland, D G Altman
Nov 18, 2000·Journal of the American College of Cardiology·P G AgostoniG Marenzi
Oct 29, 2003·Circulation·Piergiuseppe AgostoniKarlman Wasserman
Feb 24, 2004·American Journal of Respiratory and Critical Care Medicine·Anagha R PhansalkarConnie C W Hsia
Dec 25, 2004·European Heart Journal·Piergiuseppe AgostoniPietro Palermo
Aug 2, 2005·The European Respiratory Journal·M R MillerUNKNOWN ATS/ERS Task Force
Oct 10, 2006·European Heart Journal·Piergiuseppe AgostoniCesare Fiorentini
Jan 16, 2007·Respiratory Physiology & Neurobiology·Juan M Murias, Gerald S Zavorsky
Jan 19, 2007·Respiratory Medicine·Ivo van der LeeJan-Willem J Lammers
Feb 13, 2010·Journal of Applied Physiology·Colin D R BorlandConnie C W Hsia
Mar 26, 2011·Journal of Applied Physiology·Piergiuseppe AgostoniUNKNOWN HIGHCARE Investigators
Jan 22, 2013·Respiratory Physiology & Neurobiology·Gerald S Zavorsky
Oct 25, 2013·Scandinavian Journal of Medicine & Science in Sports·K M LavinG S Zavorsky
Oct 30, 2013·European Journal of Preventive Cardiology·Alessandra MaginiPiergiuseppe Agostoni
Nov 23, 2013·Journal of Applied Physiology·Colin BorlandAlain Vuylsteke
Mar 10, 2016·Respiratory Physiology & Neurobiology·Hervé Jean-Pierre GuénardChristian Kays
Nov 20, 2016·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Bryan J TaylorBruce D Johnson
Dec 26, 2016·Respiratory Physiology & Neurobiology·Kirsten E CoffmanBruce D Johnson
Jan 4, 2017·Respiratory Physiology & Neurobiology·M-Y KangB Sapoval
Feb 10, 2017·The European Respiratory Journal·Gerald S ZavorskyAnh Tuan Dinh-Xuan
May 3, 2019·International Journal of Cardiology·Piergiuseppe Agostoni, Daniel Dumitrescu
Jun 9, 2020·Respiratory Physiology & Neurobiology·Alessandra MaginiPiergiuseppe Agostoni
Aug 18, 2020·Respiratory Physiology & Neurobiology·Kazuhiro YamaguchiShinji Abe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.